The Hong Kong government recently launched a large-scale vaccination campaign against the CCP (Chinese Communist Party) virus, also known as COVID-19, but there have been several reports of severe side effects. 13 people died in Hong Kong after being inoculated in less than a month, 11 of whom were given the Sinovac vaccine, a Chinese domestically produced vaccine.
After announcing the administration of 100 million doses of the Sinovac vaccine in China on March 28, the CCP has not confirmed a single case of severe side effects or death.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
However, there are four peculiar characteristics of the Chinese Sinovac vaccine, which are discussed below.
In China, no deaths have been reported.
On Feb. 28, the first death after vaccination was confirmed in Hong Kong. In only one month, 13 people in Hong Kong, ranging in age from 55 to 80, died after receiving the vaccine. The Sinovac shots were given to eleven of them, while the BioNTech shots were given to the other two.
Furthermore, on March 20, an elderly woman in her eighties died at home the day after receiving the Sinovac vaccine, but the Hong Kong Department of Health failed to record or publicize the incident. “There was no clear causal association between her death and vaccination, thereby not meeting the reporting requirements of AEFIs (Adverse Events Following Immunization),” the Department of Health replied in the early hours of March 31.
Yuen Hoi Man, the Democratic Party of Hong Kong’s deputy spokesman for medical policy, said the government was depriving the public of its right to know by not publishing the details in an interview with The Epoch Times.
Even though there is no direct relationship, he believes the government should be honest if an indirect relationship cannot be ruled out.
In an interview with The Epoch Times, Dr. Cheung Wai Lit, a Chinese medicine doctor, also said that he believed there were other instances of death after getting the Chinese vaccine, but that there was no way for outsiders to confirm it.
Authorities in Hong Kong replied on March 30 to the deaths of 13 people after obtaining the vaccine, saying that current evidence shows that the majority of the cases died of cardiovascular disease and that none of the individual cases were directly linked to the vaccination.
However, in an interview with The Epoch Times, Law Cheuk You, staff and vice-chairman of the Hong Kong Hospital Authority, said that “generally speaking, the risk of any indirect side effects is not to be fully ruled out,” and that “in reality, many drugs have [side effects].”
According to Law, there have been cases of death in other countries following COVID-19 vaccination. However, even if there isn’t a direct link, the authorities can still provide information. Others would be able to select the necessary steps based on the data.
On March 30, Germany reported that over 2.7 million people had received the AstraZeneca vaccine as of March 29, and that 31 people had developed blood clots, with 9 deaths. As a result, the German government agreed to stop administering the vaccine to citizens under the age of 60.
Canada also declared on March 29 that it is halting the use of the AstraZeneca vaccine for people under the age of 55 due to reports of unusual blood clots, despite the fact that no cases have been reported in the country at this time.
Despite suspending the use of BioNTech shots due to packaging defects, the Hong Kong government has yet to stop using the Sinovac vaccine, which has resulted in 11 deaths out of a total of around 450,000 people vaccinated in a month. This has sparked public outrage.
Law claims that there is inadequate statistical evidence on the Sinovac vaccine’s use in people over 60, and that the vaccine’s Phase III clinical data has not been released in peer-reviewed medical journals. Despite this, the Hong Kong government continues to require that the elderly receive the vaccine. He advised people to only get vaccines that have enough scientific evidence.
Yuen Hoi Man has recommended that individuals over the age of 60 and those with chronic diseases be exempt from receiving the Sinovac vaccine.
On March 28, the CCP’s National Health Commission announced that more than 100 million doses of domestic vaccines had been administered in China, but that no deaths or severe side effects had been recorded. At the same time, any complaints about the vaccines’ side effects are easily removed from China’s internet.
In countries where Sinovac vaccines are used, the epidemic is becoming more severe.
The United Kingdom was the first country to begin COVID-19 vaccines, authorizing the BioNTech vaccine in December and the AstraZeneca vaccine in January of this year. After Jan. 9, their epidemic started to subside. On March 27, the UK reported 4,715 cases, down from 6,187 cases the day before. The outbreak slowed considerably after vaccination in the United States and Israel, where the BioNTech vaccine was also selected as the main vaccine.
In February, Chile administered nearly 9 million Sinovac vaccine doses, an average of 47 doses per 100 people, making it the South American country with the highest vaccination rate. However, rather than declining, the number of positive test results in Chile increased, hitting a record high of 7,626 cases in a single day on March 26, resulting in a shortage of hospital beds and a recent lockdown of the capital city of Santiago.
Turkey began administering Sinovac vaccines in mid-January, and at least eight million people, or more than ten percent of the population, have received the vaccine. However, their case numbers began to rise again in late February, with 37,303 new cases recorded on March 30, the highest single-day total since the epidemic began on March 11 last year.
Furthermore, Pakistan, which has been using the Chinese vaccine since early February, is now witnessing a third wave of the pandemic, with the national positivity rate reaching 11%, the highest level since the epidemic began. Owing to the magnitude of the outbreak, more than 20 cities have been declared “closed.”
On March 29, Pakistani President Arif Alvi wrote that he had tested positive after obtaining the first dose of a vaccine developed by the Chinese National Pharmaceutical Group Corp on March 15. Prior to that, Pakistani Prime Minister Imran Khan tested positive for the virus on March 18, just two days after getting his first dose of the same Chinese company’s vaccine.
